7:45 AM - 8:45 AM
Registration & Refreshments
8:45 AM - 8:50 AM
8:50 AM - 9:35 AM - Panel Discussion
Technology & Innovation
How Will AI and Machine-Learning Technologies Change our Industry?
Sebastian Kube, Senior Data Scientist, Boehringer Ingelheim
Adrian Funke, Head of CMC Predictive Development Bayer Science Fellow, Bayer
Lorenzo Gentiluomo, Associate Principal Scientist, Lonza
Sune Andersen, Principal Scientist in Particle Engineering, Janssen
Dr. Angela Lopez del Rio, Scientist , Boehringer Ingelheim
9:40 AM - 10:10 AM - Case Studies
Small Molecules
Process Intensification of Solid Oral Dosage Forms Manufacturing via Semi-Continuous Fluidized Bed Granulation
Adrian Funke, Head of CMC Predictive Development Bayer Science Fellow, Bayer
Biologics
Supercharging Proteins with Multivalent Excipients is a Much More Effective Strategy for Increasing Aggregation Resistance than Using Mutagenesis
Robin Curtis, Senior Lecturer, University of Manchester
Technology & Innovation
25 Years After the Ro5 – Trends in the Chemical Space and Drug Delivery
Sven Stegemann, Professor, Graz University of Technology
Device Development
Impact of the EU MDR on the Risk Management Process for Drug-Device Combination Products
10:15 AM - 10:45 AM - Solution Spotlights
Small Molecules
Technologies and Patient Centric Solutions to Address the Paradigm “Treat the Patient, not the Disease
Luigi Boltri, Senior Director, Pharmaceutical Sciences, Adare
Biologics
NOT ON DEMAND | Trehalose and Sucrose: Essential components of Platform Biopharma Formulations and Covid 19 Applications
Christian Lotz, General Manager EMEA, Pfanstiehl GmbH
Technology & Innovation
Transformational Drug Load Improvements in Injectable Hydrogels – The Power of Small Particles
Tamas Solymosi, Lead Scientist , Nanoform
Device Development
Focus on Patients and Medical Devices for Subcutaneous Drug Delivery
Dr. Sabine Websky, Head Medical Affairs & Applied Technologies , Gerresheimer
10:45 AM - 11:35 AM
1-2-1 Pre-Scheduled Meetings & Networking Break
11:35 AM - 12:05 PM - Case Studies
Small Molecules
New Insights in the Endothelial Transport of Orally Administered PEGylated Mixed Micelles
Rene Van Nostrum, Associate Professor, Pharmaceutical Sciences, Utrecht University
Biologics
Developability Assessment of Biologics and Formulation of Novel Molecules
Shahid Uddin, Director of Formulation & Stability, Immunocore
Technology & Innovation
Novel Nanotechnologies for Mucosal Delivery of Small Molecules and Biologics: Old Problems but New Solutions
Device Development
Parenteral Drug-Device Combination Products – Data Package, Integrated Control Strategy, and Platform Approach for Successful Submissions
12:10 PM - 12:40 PM - Solution Spotlights
Small Molecules
Dispersome® – Novel Bioavailability Enhancement Technology for Poorly Water-Soluble APIs Scalable from Grams to Tons
Pedro Valente, R&D Director - Oral Drug Product Development, Hovione
Korbinian Lobmann, CSO, Zerion Pharma
Biologics
Lycagel® : Soft Capsule Performance/ Stability vs Gelatin
Steve Amoussou-Guenou, Global Technical Developer, Roquette
Technology & Innovation
Extended-Release Depot Technologies and Advanced Delivery Modalities Utilizing Lactide-Glycolide Chemistry
Patrick Duffy, R&D Team Leader, Manufacturing Manager for Bioresorbable Polymers, Ashland
Technology & Innovation
Controlled and Long-Acting Release for Ophthalmic and Sub-cutaneous Administration with Biodegradable DelSiTech Silica Matrix Technology
Frederic Dargelas, Head of Business Development and Alliance Management , DelSiTech Ltd
12:40 PM - 12:55 PM
Poster Presentations
12:55 PM - 1:55 PM
Networking Lunch
1:55 PM - 2:25 PM - Case Studies
Small Molecules
Novel Twin-Screw Granulation Technologies for Increased Drug Solubility and Bioavailability
Biologics
NOT ON DEMAND | Improved Biopharmaceutical Properties for Amorphous Oral Dosage Forms of Poorly Soluble Drugs
Andreas Fischer, Senior Principal Scientist, Xspray Pharma
Technology & Innovation
NOT ON DEMAND | Challenges In Development Of Highly Drug Loaded, Redispersible API Nanoparticle Containing Tablets
Christoph Nüboldt, Scientist , Invite-GmbH
Device Development
Aerosol Modeling for Development and Assessment of Novel Inhalation Products
Arkadiusz Kuczaj, Manager Aerosol Innovation and Dosimetry, Philip Morris International R&D
2:30 PM - 3:00 PM - Solution Spotlights
Small Molecules
NOT ON DEMAND | Formulation and Processing Considerations with Long-Acting PLGA-Based Microparticles or Implants
Roland Bodmeier, Managing Director, Pensatech Pharma GmbH
Biologics
Biodegradable Polymer-Based Drug Delivery Technologies for Development of Tomorrow’s Long-Acting Injectable Medicine
Rob Steendam, Chief Technology Officer, InnoCore Pharmaceuticals
Technology & Innovation
Innovative Gastro-Retentive and Chronotherapeutic Drug Delivery Technologies for Reinventing Challenging Compounds
Pavan Handa, Senior Vice President, Specialty Portfolio Management, Amneal Pharmaceuticals
Dipen Desai, Vice President Formulation & Analytical, Amneal Pharmaceuticals
Device Development
NOT ON DEMAND | Miniature Active Implants – The Key Area for Innovation in Next-Generation Drug Delivery
Harshal Shah, Head of Global BioPharma Commercial, Cambridge Consultants
3:00 PM - 3:15 PM
Poster presentations
3:15 PM - 4:05 PM
1-2-1 Pre-Scheduled Meetings & Networking Break
4:05 PM - 4:35 PM - Case Studies
Small Molecules
NOT ON DEMAND | Early Developability Assessment, Key to Success for Development Phases
Philippe Lienard, Early Development Coordinator, Pasteur Institute
Biologics
Biopharmaceutics of mAbs: Challenges in Subcutaneous Bioavailability Prediction
Mikolaj Milewski, Principal Scientist, MSD
Technology & Innovation
Transforming Rectal Therapies for Ulcerative Colitis Using Novel Hydrogel Formulation
Ravi Pamnani, CEO, Intact Therapeutics
Technology & Innovation
Dissolution & Biopharmaceutics applications in Pharmaceutical R&D
Christian Jede, Scientific Associate Director, Merck Healthcare KGaA
4:40 PM - 5:10 PM - Case Studies
Small Molecules
Advanced Medicated Dressings as Delivery Platforms for Chronic Wound Healing
Biologics
Photodegradation of Therapeutic Antibodies
Patrick Garidel, Head of Process, Purification and Pharma Development, Boehringer Ingelheim
Technology & Innovation
NOT ON DEMAND | Biopredictive Tools for the Development of Injectable Drug Products
Matthias Gerhard Wacker, Associate Professor, National University of Singapore
Device Development
Designing Medications with Human Behavior in Mind
5:15 PM - 6:00 PM - Panel Discussion
Biologics
Latest Advances in the Oral Delivery of Biologics
Patrick Garidel, Head of Process, Purification and Pharma Development, Boehringer Ingelheim
Dr. Stefan Bracht, Vice President Head of Drug Delivery Innovation, Bayer
Thomas von Erlach, Co-Founder and Chief Scientific Officer, Vivtex
6:00 PM - 6:05 PM
6:05 PM - 7:05 PM
Evening Networking Reception
8:00 AM - 8:30 AM
Registration & Refreshments
8:30 AM - 8:35 AM
8:35 AM - 9:05 AM - Keynote
Biologics
Polymers and Peptides for Stabilization and Targeted Delivery of Nucleic Acids in Vivo
Dr. Manfred Ogris, Professor Department of Pharmaceutical Sciences, University of Vienna
9:10 AM - 9:40 AM - Case Studies
Small Molecules
NOT ON DEMAND | Value Added Reformulations Using Novel Technologies
Biologics
From Liposomes over Lipoplexes to LNPs and back: Nanoparticle Drug Delivery Technologies for RNA
Dr. Heinrich Haas, Vice President Formulation & Drug Delivery , BioNTech
Technology & Innovation
NOT ON DEMAND | Oral Biologics Delivery
Thomas von Erlach, Co-Founder and Chief Scientific Officer, Vivtex
Device Development
NOT ON DEMAND | Considerations in Formulation and Device Development for Plasma Derived Therapies
Andreas Liebminger, Head of PDT PharmSci & Devices, Takeda
9:45 AM - 10:15 AM - Solution Spotlights
Small Molecules
Modified Release Development Strategies to Achieve Your Target Product Profile
Andrew Lewis, Vice President, Pharmaceutical Sciences, Quotient Sciences
Biologics
Surfactants in Bioformulation: Are We at the End or the Beginning of a Journey?
Philipp Hebestreit, Regional Technical Service Manager , BASF
Technology & Innovation
NOT ON DEMAND | Continuous Manufacturing: Rheological Powder Characterisation of Excipients to Understand Their Behaving During the Feeding Step
Vanessa Havenith, Technical Sales Manager, SE Tylose GmbH & Co. KG
Device Development
Dissolvable Microneedles – From Product Development to Commercial Manufacturing
Dr. Sebastian Braun, Director Business Development MAP, LTS Lohmann Therapie-Systeme AG
10:15 AM - 10:30 AM
Poster Presentations
10:30 AM - 11:20 AM
1-2-1 Pre-Scheduled Meetings & Networking Break
11:20 AM - 11:50 AM - Case Studies
Small Molecules
Challenges of Downstream Manufacturing of Amorphous Solid Dispersions
Tatiana Marcozzi, Senior Scientist – Oral Solid Development, Janssen
Biologics
Thermokinetic Modelling of Biologics as a Tool for Accelerating Development
Technology & Innovation
mRNA/LNP Formulations from Therapeutics to Vaccines
Erik Oude Blenke, Associate Principle Scientist, AstraZeneca
Device Development
Connecting the Dots in the User Experience of Self-Injection
Soren Skov, Senior Expert Human Factors / User Experience , Novartis
11:55 AM - 12:25 PM - Solution Spotlights
Technology & Innovation
ChemoSeed®: An implantable drug delivery technology for the localised treatment of High Grade Gliomas
Dr. Chris McConville, Chief Scientific Officer, Extruded Pharmaceuticals Ltd
Biologics
Understanding Biopharmaceutical Detergents
James Humphrey, Research & Technology Specialist, Croda Pharma
Small Molecules
NOT ON DEMAND | Molecular Modelling to Support Drug Formulation for Small Molecule and Biologic Drugs
John C. Shelley, Fellow, Schrödinger
Biologics
Oral delivery of Non-Absorbed Biomolecules to the GI tract
Carol Thomson, Chief Executive Officer , BDD Pharma
12:30 PM - 1:00 PM - Case Studies
Small Molecules
Multicomponent Co-Crystals Manufactured via HME
Dunja Šilić, Senior Product Development Scientist, Pliva
Biologics
Modelling Rheology of Highly Concentrated Proteins
Technology & Innovation
Solvent-Free Material Processing for the Development of Drug Delivery Systems Using Supercritical Carbon Dioxide (scCO2)
Vivek Trivedi, Senior Lecturer in Drug Delivery, University of Kent
Device Development
Design Verification of Combination Products
Ajay Bapurao Chintawar, Drug Delivery Systems Development Lead , Pharmathen
1:00 PM - 1:15 PM
Poster Presentations
1:15 PM - 2:15 PM
Networking Lunch
2:15 PM - 2:45 PM - Case Studies
Small Molecules
Printing of Non-Printable: 3D Printing of Pharmaceutical Oral Solid Dosage Forms by a Fused Deposition Method
Valentyn Mohylyuk, Pharmaceutical Scientist (research fellow), Queen's University Belfast
Biologics
Nanotechnology - Past, Present and Future
Vimalkumar Balasubramanian, Principal Scientist , Bayer
Device Development
Combination Products Under MDR (article 117)
2:50 PM - 3:20 PM - Solution Spotlights
Small Molecules
NOT ON DEMAND | An End-to-End Pharmaceutical Development Pathway to Rapidly Bring Poorly Soluble New Chemical Entities to the Market
Alexandre Gil , Ph.D., Director, Business Development , WuXi STA
Biologics
NOT ON DEMAND | Polymeric Implants for the Long-Acting Delivery of Biologics
Dr. Christina Schmid, Application Development Manager – Pharmaceuticals, Celanese Corp
Technology & Innovation
Creating the Future of Solubility and Bioavailability Enhancement with Apisolex™ and Apinovex™ Polymers
Nick DiFranco, MEM, Global Market Segment Manager for Oral Treatments, Lubrizol Life Science Health
Robert W. Lee, President of the CDMO Division, Lubrizol Life Science Health
Device Development
Article 117 - Approaches for Integral Drug-Device Combination Product Platforms
Beat U. Steffen, Founder & CEO , confinis ag
3:20 PM - 4:10 PM
1-2-1 Pre-Scheduled Meetings & Networking Break
4:10 PM - 4:40 PM - Case Studies
Small Molecules
Miniaturization of the Dry Granulation Process to Accelerate the NCE Drug Development
Corentin Larcy, NCE Drug Product Expert, UCB
Technology & Innovation
3D Printed Drug Delivery Systems & Biodegradable Implants
Dimitrios Lamprou, Professor & MSc Director, Queen’s University Belfast
Technology & Innovation
Understanding the Interaction Mechanisms Between Drugs and Cellular Membranes: Unique Insight from the Novel Application of Laser and Neutron Reflection Techniques
Dr Richard A. Campbell, Senior Lecturer in Physical Pharmacy, University of Manchester
Device Development
The Design Development and Commercialization of a High Accuracy Low Volume Dosing Syringe
4:45 PM - 5:15 PM - Keynote
Technology & Innovation
Formulation & Device Lifecycle Management for Biotherapeutics - The Value of Platform Technologies
Beate Bittner, Product Optimization Franchise Leader, Roche
5:15 PM - 5:25 PM
13th Global Drug Delivery & Formulation Summit Poster Competition Award
5:25 PM - 5:30 PM
5:30 PM - 6:30 PM
Evening Networking Reception
8:30 AM - 8:55 AM
Registration & Refreshments
8:55 AM - 9:00 AM
9:00 AM - 9:30 AM - Keynote
Technology & Innovation
Oral Drug Delivery for Beyond Rule of Five Molecules – Chemical and Physical Approaches
Dr. Stefan Bracht, Vice President Head of Drug Delivery Innovation, Bayer
9:30 AM - 10:00 AM - Keynote
Device Development
Improving Dose Accuracy for Auto-Injector Products by Applying Optimized Manufacturing Settings & Choosing Enhanced Release Test Methodology
Imad Sallit, Senior Technical Steward Devices, Novartis
Anja Dörfler, Senior Technical Transfer Lead, Novartis
10:05 AM - 10:35 AM - Case Studies
Small Molecules
NOT ON DEMAND | A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development
Samuel Kyeremateng, Principal Scientist , Abbvie
Biologics
A Photostability Testing Strategy for High Throughput Formulation Screenings
Paulina Luisa Fischer, PhD Student, AbbVie
Technology & Innovation
A Journey at the Wonderful World of Microfluidics in Nanomedicine
Dimitrios Lamprou, Professor & MSc Director, Queen’s University Belfast
Technology & Innovation
NOT ON DEMAND | Computer-Aided Formulation Development: From Early Excipient Screening to Final Formulation
Gabriele Sadowski, Professor Laboratory for Thermodynamics, TU Dortmund University
10:40 AM - 11:10 AM - Solution Spotlights
Small Molecules
Observations of Tribo-Charging Two Separate Filler-Binders for Continuous Manufacturing Operations
Michael Black, Head of Sales Pharma, Beneo
Biologics
Accelerating the Development of RNA-Based Medicines: A Case Study on Developing an mRNA-LNP-based COVID-19 Vaccine
Dr. Martin Rabel, Field Application Scientist
Technology & Innovation
A Transition from Batch to Continuous Mixing
Dr. Sara Fathollahi, Product Application Specialist, Oral Solid Dosage, DFE Pharma
Device Development
Overcoming the Delivery Challenges for Next-Generation Therapies
Matt Parker, Senior Consultant – Drug Delivery, TTP
11:10 AM - 12:00 PM
1-2-1 Pre-Scheduled Meetings & Networking Break
12:00 PM - 12:30 PM - Case Studies
Small Molecules
NOT ON DEMAND | Selection of the Spray-Drying Process Design Space for an ASD Formulation via Thermodynamic Modelling
Stefanie Dohrn, Principal Scientist, AbbVie
Biologics
NOT ON DEMAND | Novel Nanosystems for Oral Delivery of Biologics
Driton Vllasaliu, Senior Lecturer in Pharmaceutics, King’s College London
Technology & Innovation
Pediatric Formulation Development –Patient Centricity for the Pediatric Population
Leonie Wagner, Senior Formulation Scientist, Roche
Technology & Innovation
Electrospinning of Amorphous Solid Dispersions
Sune Andersen, Principal Scientist in Particle Engineering, Janssen
12:35 PM - 1:05 PM - Solution Spotlights
Small Molecules
Polymer-Based Excipients in Drug Delivery: Solubility Enhancement Technology for Hydrophobic APIs
Thomas Delacroix, R&D Director , PMC Isochem
Biologics
Inhaled Delivery of Biologics: Why it’s a Good Solution
Mark Parry, Technical Director, Intertek Melbourn
Technology & Innovation
Particle Size Control Through Micronization: Challenges and Solutions
Salvatore Mercuri, Associate Director, NPI & MSAT, Monteggio, Lonza
1:05 PM - 2:05 PM
Networking Lunch
2:05 PM - 2:35 PM - Case Studies
Small Molecules
NOT ON DEMAND | Nanotechnology for Solvent-free Production of Amorphous Solid Dispersions
Christoph Nüboldt, Scientist , Invite-GmbH
Biologics
Novel Formats of Protein Therapeutics: Challenges in Development
Sven Amrhein, Principal Scientist, Roche
Technology & Innovation
Scratching the Surface – Surface Characterization of Pharmaceutical Powders for Oral Solid Dosage Forms
Lena Mareczek, Scientist, Merck KGaA
2:40 PM - 3:10 PM - Case Studies
Small Molecules
Machine Learning-Enhanced Sub-Visible Particles Analytics
Dr. Angela Lopez del Rio, Scientist , Boehringer Ingelheim
Technology & Innovation
Biopharmaceutics Tools to Understand Performance of Parenteral Liposomal
Nikoletta Fotaki, Reader in (Bio)Pharmaceutics, University of Bath
Biologics
NOT ON DEMAND | Peptide Nanomaterials for Drug Delivery: A Preliminary Study of Diphenylalanine
Wenqian Chen, Assistant Professor , National University of Singapore
Small Molecules
HME as an Advanced Continuous Technology for The Manufacture of Age-appropriate Anti-Malarial Combinations
Suha Dadou, Research Fellow, Queen’s University Belfast
Valentyn Mohylyuk, Pharmaceutical Scientist (research fellow), Queen's University Belfast
3:15 PM - 3:45 PM - Keynote
Technology & Innovation
The Path Towards Clinically Relevant Specifications – Challenges and Solutions
Christophe Tistaert, Principal Scientist , Janssen Research & Development
3:45 PM - 3:50 PM